Chronic Intestinal Pathologies Analytical Cohort at TouLouse
NCT04896684
Summary
In the general population, the percentage of people with at least one digestive disease is 16.7%. Among these digestive diseases, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and patients who should benefit from digestive examinations as part of a screening oriented either by the patient's family history or following the performance of an immunological screening test ( FIT) in the stool will be studied. The aim of this project is to build a biological collection with associated clinical data for research projects.
Eligibility
Inclusion Criteria: * Patient requiring endoscopic explorations for screening or follow-up in the context of a suspected IBS or IBD or colorectal cancer Or * Patient with IBD requiring surgical management * Patient over 18 years old * Patient able to read and understand the information leaflet * Patients who have given their consent to participate in the study * Patients affiliated to a social security system (including AME) Exclusion Criteria: * Patients who have received antibiotic treatments in the 10 days preceding endoscopic exploration * Pregnant or breastfeeding patients * Patients under 18 years old * Patients under guardianship or curatorship * Patients unable to sign a free and informed consent
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT04896684